Kastelein Johannes Jacob Pieter bought NAMS
January 7, 2026 · Form 4 insider transaction
Kastelein Johannes Jacob Pieter bought 25,500 shares of NewAmsterdam Pharma Company N.V., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,500
Price
N/A
Total value
N/A
RoleOfficer, Director
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateJanuary 7, 2026
Filing dateJanuary 7, 2026
Shares owned after98,981
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents RSUs, each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date.; Each RSU was granted on January 7, 2026 for no consideration.